{"title":"骶髂关节注射成功治疗现代SARS-CoV-2疫苗第三剂(加强剂)后的骶髂炎","authors":"Nishant Modi, MD, Prem Darji, MD, Iman Rabizadeh, MD, Syed Ali, MD","doi":"10.36076/pmcr.2022.6.281","DOIUrl":null,"url":null,"abstract":"BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread across the world causing the coronavirus disease 2019. Due to high infectious spread, 2 messenger RNA vaccines, Pfizer-BioNTech and Moderna, were the first SARS-CoV-2 vaccines authorized in the United States. CASE REPORT: We report a rare case of a 19-year-old woman who developed isolated sacroiliitis following the third (booster) dose of the Moderna vaccination. CONCLUSIONS: While most vaccine adverse effects are self-resolved, we describe a unique case of isolated sacroiliitis after the SARS-CoV-2 vaccination, which was then successfully treated with sacroiliac joint injection after failing medical management. KEY WORDS: COVID-19, sacroiliitis, pain management, sacroiliac joint injection, Moderna, vaccination, case report","PeriodicalId":122753,"journal":{"name":"Pain Medicine Case Reports","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sacroiliitis Following Third (Booster) Dose of Moderna SARS-CoV-2 Vaccination Treated Successfully With Sacroiliac Joint Injection\",\"authors\":\"Nishant Modi, MD, Prem Darji, MD, Iman Rabizadeh, MD, Syed Ali, MD\",\"doi\":\"10.36076/pmcr.2022.6.281\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread across the world causing the coronavirus disease 2019. Due to high infectious spread, 2 messenger RNA vaccines, Pfizer-BioNTech and Moderna, were the first SARS-CoV-2 vaccines authorized in the United States. CASE REPORT: We report a rare case of a 19-year-old woman who developed isolated sacroiliitis following the third (booster) dose of the Moderna vaccination. CONCLUSIONS: While most vaccine adverse effects are self-resolved, we describe a unique case of isolated sacroiliitis after the SARS-CoV-2 vaccination, which was then successfully treated with sacroiliac joint injection after failing medical management. KEY WORDS: COVID-19, sacroiliitis, pain management, sacroiliac joint injection, Moderna, vaccination, case report\",\"PeriodicalId\":122753,\"journal\":{\"name\":\"Pain Medicine Case Reports\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pain Medicine Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36076/pmcr.2022.6.281\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pain Medicine Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36076/pmcr.2022.6.281","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Sacroiliitis Following Third (Booster) Dose of Moderna SARS-CoV-2 Vaccination Treated Successfully With Sacroiliac Joint Injection
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread across the world causing the coronavirus disease 2019. Due to high infectious spread, 2 messenger RNA vaccines, Pfizer-BioNTech and Moderna, were the first SARS-CoV-2 vaccines authorized in the United States. CASE REPORT: We report a rare case of a 19-year-old woman who developed isolated sacroiliitis following the third (booster) dose of the Moderna vaccination. CONCLUSIONS: While most vaccine adverse effects are self-resolved, we describe a unique case of isolated sacroiliitis after the SARS-CoV-2 vaccination, which was then successfully treated with sacroiliac joint injection after failing medical management. KEY WORDS: COVID-19, sacroiliitis, pain management, sacroiliac joint injection, Moderna, vaccination, case report
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
